The global liquid embolic agent market, valued at USD 243.90 million in 2024 and projected to grow at a 9.7 percent CAGR through 2034, is shaped significantly by contributions from high-performance countries. The United States leads within North America, propelled by high procedure volumes, established clinical infrastructure, and favorable reimbursement. China is one of the fastest growing...
Bangla